Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
QIAGEN N.V.
Bear Case (25th pct.)
-35.3% vs price
Base Case (Median)
-14.0% vs price
Bull Case (75th pct.)
5.6% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $47.98 | 10.7% | High (40%) |
| PE Comparable | $43.54 | 0.5% | Medium (25%) |
| Growth Trajectory DCF | $89.54 | 106.6% | Medium (20%) |
| Graham Number | $27.55 | -36.4% | Medium (40%) |
| EV/EBITDA | $28.54 | -34.1% | Medium (20%) |
| EV/FCF | $37.25 | -14.0% | Medium (20%) |
| Earnings Power Value | $16.85 | -61.1% | Medium (50%) |
Based on 7 out of 7 methods, QGEN appears fairly valued at the current price of $43.33. The base case fair value of $37.25 implies 14.0% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.